Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Rifai, W.'e.
Right arrow Articles by Powell, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Rifai, W.'e.
Right arrow Articles by Powell, S. M.
[Cancer Research 62, 4061-4064, July 15, 2002]
© 2002 American Association for Cancer Research


Molecular Biology and Genetics

Gastric Cancers Overexpress DARPP-32 and a Novel Isoform, t-DARPP1

Wa’el El-Rifai2, Michael F. Smith, Jr., Guolian Li, Andy Beckler, Virginia S. Carl, Elizabeth Montgomery, Sakari Knuutila, Christopher A. Moskaluk, Henry F. Frierson, Jr. and Steven M. Powell

Departments of Medicine [W. E-R., M. F. S., G. L., A. B., V. S. C., S. M. P.], Microbiology [M. F. S.], and Pathology [C. A. M., H. F. F.], University of Virginia Health System, Charlottesville, Virginia 22908-0708; Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21230 [E. M.]; and Department of Medical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, 00290 Finland [S. K.]

Gastric carcinoma is the second most common cause of cancer-related death worldwide. Recently, we have demonstrated that expressed sequencetag AA552509 was frequently amplified and the most consistently overexpressed target at 17q in gastric cancers. Herein, we report that DARPP-32 (dopamine and cAMP-regulated phosphoprotein of Mr 32,000) is the target gene for overexpression of expressed sequence tag AA552509. In addition, we have identified full-length cDNA of DARPP-32 (GenBank accession number AF464196) with 467 bp of additional untranslated mRNA nucleotides upstream of the previously known translation start site in exon 1. Additionally, we have discovered a novel truncated isoform of DARPP-32 that we named t-DARPP (GenBank accession number AY070271), which is also overexpressed in gastric cancers. Using quantitative real-time reverse transcription-PCR, Western blots, and staining of tumor tissue arrays, the two DARPP mRNA transcripts and proteins were overexpressed in gastric cancer cells and exhibited abundant protein overexpression in neoplastic but not normal gastric epithelial cells. DARPP-32 is the only known protein that acts as a protein phosphatase 1 inhibitor or a protein kinase A inhibitor. The novel truncated isoform, t-DARPP, lacks the phosphorylation site related to protein phosphatase 1 inhibition but maintains the phosphorylation site with the protein kinase A inhibitory effect. Our results reveal for the first time the presence of these signaling molecules in human cancer and suggest that they may be important for gastric tumorigenesis.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L. Gu, S. K. Lau, S. Loera, G. Somlo, and S. E. Kane
Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
Clin. Cancer Res., December 1, 2009; 15(23): 7196 - 7206.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Hansen, J. Howlin, A. Tengholm, O. Dyachok, W. F. Vogel, A. C. Nairn, P. Greengard, and T. Andersson
Wnt-5a-induced Phosphorylation of DARPP-32 Inhibits Breast Cancer Cell Migration in a CREB-dependent Manner
J. Biol. Chem., October 2, 2009; 284(40): 27533 - 27543.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Belkhiri, A. A. Dar, D. F. Peng, M. H. Razvi, C. Rinehart, C. L. Arteaga, and W. El-Rifai
Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells
Clin. Cancer Res., July 15, 2008; 14(14): 4564 - 4571.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Belkhiri, A. A. Dar, A. Zaika, M. Kelley, and W. El-Rifai
t-Darpp Promotes Cancer Cell Survival by Up-regulation of Bcl2 through Akt-Dependent Mechanism
Cancer Res., January 15, 2008; 68(2): 395 - 403.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Maqani, A. Belkhiri, C. Moskaluk, S. Knuutila, A. A. Dar, and W. El-Rifai
Molecular Dissection of 17q12 Amplicon in Upper Gastrointestinal Adenocarcinomas
Mol. Cancer Res., July 1, 2006; 4(7): 449 - 455.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
P Kauraniemi and A Kallioniemi
Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.
Endocr. Relat. Cancer, March 1, 2006; 13(1): 39 - 49.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Garcia-Jimenez, M. A. Zaballos, and P. Santisteban
DARPP-32 (Dopamine and 3',5'-Cyclic Adenosine Monophosphate-Regulated Neuronal Phosphoprotein) Is Essential for the Maintenance of Thyroid Differentiation
Mol. Endocrinol., December 1, 2005; 19(12): 3060 - 3072.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Belkhiri, A. Zaika, N. Pidkovka, S. Knuutila, C. Moskaluk, and W. El-Rifai
Darpp-32: a Novel Antiapoptotic Gene in Upper Gastrointestinal Carcinomas
Cancer Res., August 1, 2005; 65(15): 6583 - 6592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. H. Johnson, H. F. Frierson, A. Zaika, S. M. Powell, J. Roche, S. Crowe, C. A. Moskaluk, and W. El-Rifai
Expression of Tight-Junction Protein Claudin-7 Is an Early Event in Gastric Tumorigenesis
Am. J. Pathol., August 1, 2005; 167(2): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
J Malta-Vacas, C Aires, P Costa, A R Conde, S Ramos, A P Martins, C Monteiro, and M Brito
Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types
J. Clin. Pathol., June 1, 2005; 58(6): 621 - 625.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N Koon, R Schneider-Stock, M Sarlomo-Rikala, J Lasota, M Smolkin, G Petroni, A Zaika, C Boltze, F Meyer, L Andersson, et al.
Molecular targets for tumour progression in gastrointestinal stromal tumours
Gut, February 1, 2004; 53(2): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.'e. El-Rifai, C. A. Moskaluk, M. K. Abdrabbo, J. Harper, C. Yoshida, G. J. Riggins, H. F. Frierson Jr., and S. M. Powell
Gastric Cancers Overexpress S100A Calcium-binding Proteins
Cancer Res., December 1, 2002; 62(23): 6823 - 6826.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.